|Bid||1.1900 x 1161000|
|Ask||1.2200 x 1753300|
|Day's Range||1.1900 - 1.2200|
|52 Week Range||1.0500 - 1.7150|
|Beta (5Y Monthly)||0.53|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 23, 2021 - Nov 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.70|
Volpara Health, (ASX: VHT), a global health technology software leader providing an integrated platform for the delivery of personalized breast and lung care, further expanded its footprint in the US lung screening market with a strategic relationship with Seattle-based lung AI company RevealDx. This follows Volpara's recent collaboration agreement with leading US lung imaging company Riverain Technologies.
The decent performance at Volpara Health Technologies Limited ( ASX:VHT ) recently will please most shareholders as...
While Volpara Health Technologies Limited ( ASX:VHT ) shareholders are probably generally happy, the stock hasn't had...